Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

If You Think You Get Tips, Then This Might Change Your Mind

Here Is How One Can Buy Beauty Products From An Online Store Online shopping is becoming popular with a lot of people trying to get pretty much everything from the various sites available including beauty items, because it is convenient and there are a variety of items that people can get within a short period.… Read More »

News For This Month: Investments

Characteristics of Suitable Credit Cards for Bad Credit Issues of bad credit history are brought about when people fail to service the loans that they owe different financial institution. Having a bad credit history tends to impact negatively on individuals since they are limited from accessing loans in future. Some of the circumstances that contribute… Read More »